Medisolv Announces Acquisition of Lilac Software

Why It Matters

The integration gives providers and payers a unified, predictive view of performance, accelerating value‑based care adoption and reducing reporting burdens.

Key Takeaways

• Medisolv adds AI predictive analytics via Lilac acquisition
• Combines clinical data with claims insights for holistic quality view
• Enables scalable patient outreach and PRO‑PM collection
• Supports value‑based care reimbursement and reduces reporting burden
• Expands platform to serve both providers and payers

Pulse Analysis

Healthcare providers are under mounting pressure to demonstrate value through outcomes, cost efficiency, and patient experience. Over the past decade, artificial intelligence has moved from experimental pilots to core analytics engines that can synthesize massive clinical and financial datasets. Medisolv, already entrenched in clinical quality reporting for roughly a quarter of U.S. hospitals, seized the opportunity to broaden its portfolio by acquiring Lilac Software, a specialist in AI‑driven predictive analytics and Medicare Advantage Stars performance. The deal signals a strategic shift from pure measurement toward proactive, data‑powered care management.

The integration brings claims‑based quality measurement, HEDIS analytics, and agentic AI outreach into Medisolv’s existing clinical platform. By linking provider‑generated outcomes with payer‑derived claims data, organizations gain a 360‑degree view of performance gaps, enabling earlier risk identification and targeted interventions. Lilac’s patient‑engagement engine automates outreach for measures such as patient‑reported outcomes (PRO‑PMs) and information‑transfer workflows, dramatically reducing manual chart reviews. This unified solution not only streamlines regulatory reporting but also creates actionable insights that can be fed back into care pathways, accelerating improvement cycles under value‑based contracts.

From a market perspective, the combined offering positions Medisolv as a rare end‑to‑end analytics vendor capable of serving both providers and payers in the emerging value‑based ecosystem. Hospitals seeking to meet CMS quality benchmarks and insurers aiming to align incentives can now source a single platform that translates raw data into predictive, prescriptive actions. Competitors that remain siloed in either clinical or claims analytics may find their relevance eroding as integrated solutions become the norm. Ultimately, the acquisition accelerates the industry’s transition toward AI‑enabled, outcome‑focused care delivery and could set a new standard for quality intelligence.

Deal Summary

Medisolv, a national leader in healthcare quality data management, announced the acquisition of Lilac Software, an AI‑driven predictive analytics firm. The deal expands Medisolv’s capabilities into claims‑based quality measurement and AI‑powered predictive insights for value‑based care. The acquisition was announced on March 12, 2026.